These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17802716)

  • 21. Pityriasis rosea and activation of latent herpesvirus infections.
    Schwartz RA; Lambert WC
    J Am Acad Dermatol; 2014 Jan; 70(1):197. PubMed ID: 24355270
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of human herpesvirus-6 transcripts in carbamazepine-induced hypersensitivity syndrome by in situ hybridization.
    Watanabe T; Nakashima H; Ohmatsu H; Sakurai N; Takekoshi T; Tamaki K
    J Dermatol Sci; 2009 May; 54(2):134-6. PubMed ID: 19237268
    [No Abstract]   [Full Text] [Related]  

  • 23. [Minocycline hypersensibility syndrome].
    Gil P
    Ann Dermatol Venereol; 2000 Oct; 127(10):841-2. PubMed ID: 11060389
    [No Abstract]   [Full Text] [Related]  

  • 24. Toxic epidermal necrolysis due to zonisamide associated with reactivation of human herpesvirus 6.
    Teraki Y; Murota H; Izaki S
    Arch Dermatol; 2008 Feb; 144(2):232-5. PubMed ID: 18283181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivation of immanent herpes group virus.
    Sawada S; Takei M
    Intern Med; 2003 Feb; 42(2):140-1. PubMed ID: 12636231
    [No Abstract]   [Full Text] [Related]  

  • 26. Case reports and literature review: the association between reactivation of human herpes virus-6 and peripheral white blood cell count in patients with carbamazepine-induced hypersensitivity syndrome.
    Matsuda K; Ohnuma T; Fukuta M; Kawai M; Suzuki T; Ogawa H; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):751-4. PubMed ID: 16567028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case of drug rash with eosinophilia and systemic symptoms induced by zonisamide and reactivation of human herpes virus 7.
    Murata T; Endo Y; Katoh M; Miyachi Y; Kabashima K
    J Dermatol; 2011 Sep; 38(9):918-20. PubMed ID: 21998830
    [No Abstract]   [Full Text] [Related]  

  • 28. Carbamazepine hypersensitivity syndrome.
    Balasubramanian S; Shobhana S; Padmasani LN; Natarajan M; Rao R
    Indian Pediatr; 1999 Jan; 36(1):98-9. PubMed ID: 10709136
    [No Abstract]   [Full Text] [Related]  

  • 29. The anticonvulsant hypersensitivity syndrome.
    Handfield-Jones SE; Jenkins RE; Whittaker SJ; Besse CP; McGibbon DH
    Br J Dermatol; 1993 Aug; 129(2):175-7. PubMed ID: 7654579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus.
    Aihara M; Sugita Y; Takahashi S; Nagatani T; Arata S; Takeuchi K; Ikezawa Z
    Br J Dermatol; 2001 Jun; 144(6):1231-4. PubMed ID: 11422048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypersensitivity syndrome due to 2 anticonvulsant drugs.
    Conilleau V; Dompmartin A; Verneuil L; Michel M; Leroy D
    Contact Dermatitis; 1999 Sep; 41(3):141-4. PubMed ID: 10475512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced hypersensitivity syndrome in association with varicella.
    Tsutsumi R; Adachi K; Yoshida Y; Yamamoto O
    Acta Derm Venereol; 2015 Apr; 95(4):503-4. PubMed ID: 25350906
    [No Abstract]   [Full Text] [Related]  

  • 33. An update on pediatric cutaneous drug eruptions.
    Song JE; Sidbury R
    Clin Dermatol; 2014; 32(4):516-23. PubMed ID: 25017462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced hypersensitivity syndrome due to mexiletine hydrochloride associated with reactivation of human herpesvirus 7.
    Yagami A; Yoshikawa T; Asano Y; Koie S; Shiohara T; Matsunaga K
    Dermatology; 2006; 213(4):341-4. PubMed ID: 17135743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction.
    Aihara Y; Ito SI; Kobayashi Y; Yamakawa Y; Aihara M; Yokota S
    Br J Dermatol; 2003 Jul; 149(1):165-9. PubMed ID: 12890212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pityriasis rosea and pityriasis rosea-like eruptions.
    Drago F; Broccolo F; Agnoletti A; Drago F; Rebora A; Parodi A
    J Am Acad Dermatol; 2014 Jan; 70(1):196. PubMed ID: 24355268
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anticonvulsant hypersensitivity syndrome].
    Papp Z; Török L
    Orv Hetil; 2004 Aug; 145(32):1665-8. PubMed ID: 15384865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypersensitivity to Mirena--a rare complication.
    Pereira A; Coker A
    J Obstet Gynaecol; 2003 Jan; 23(1):81. PubMed ID: 12647710
    [No Abstract]   [Full Text] [Related]  

  • 39. Reply to: Pityriasis rosea and pityriasis rosea-like eruptions.
    Papadavid E; Panayiotides I; Dalamaga M; Giatrakou S; Stavrianeas N; Rigopoulos D; Makris M
    J Am Acad Dermatol; 2014 Jan; 70(1):196-7. PubMed ID: 24355267
    [No Abstract]   [Full Text] [Related]  

  • 40. Possible association of vascular endothelial growth factor with the development of edema in drug-induced hypersensitivity syndrome.
    Hirakawa S; Okazaki H; Sayama K; Tohyama M; Hashimoto K
    J Dermatol; 2011 Mar; 38(3):292-4. PubMed ID: 21342237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.